Screener
Viking Therapeutics VKTX Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $3.76B.
The source filing: Viking Therapeutics’s 10-Q, filed April 30, 2026. Open the filing →
- Filed
- Apr 29, 2026, 9:50 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-193315
FAQ
- What is Viking Therapeutics's market capitalization?
- Viking Therapeutics (VKTX) reported market capitalization of $3.76B in Q1 2026.
- How has Viking Therapeutics's market capitalization changed year-over-year?
- Viking Therapeutics's market capitalization increased by 38.7% year-over-year, from $2.71B to $3.76B.
- What is the long-term trend for Viking Therapeutics's market capitalization?
- Over 5 years (2020 to 2025), Viking Therapeutics's market capitalization has grown at a 55.3% compound annual growth rate (CAGR), from $440.46M to $3.98B.
- What does market capitalization mean?
- The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.
Ask your AI about Viking Therapeutics's market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude